Private Equity Archives - Gilde Healthcare

latest news
Private Equity

Gilde Healthcare company Noema Pharma raises CHF 103 million ($112 million)

Gilde Healthcare, a leading specialized healthcare investor, today announced that its portfolio company Noema Pharma, has raised an oversubscribed CHF 103 million ($112 million) Series B financing round from new and existing investors. Noema Pharma is a clinical-stage biopharma company targeting debilitating central nervous system (CNS) disorders. The financing round was completed by an international syndicate led by new investors...
March 7, 2023

Gilde Healthcare company Synexa Life Sciences celebrates its 20th anniversary

test Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights Synexa Life Sciences, a specialist biomarker and bioanalysis services provider, celebrates its 20th anniversary on March the 3rd 2023. Since its inception in 2003, Synexa Life Sciences has become a trusted partner to pharmaceutical, biotech, academic and non-profit organizations all over the […]

Gilde Healthcare sells its stake in Zetacom to facilitate a merger with Detron

test The Private Equity fund of Gilde Healthcare, the leading European specialist healthcare investor, has reached an agreement to sell its majority stake in Zetacom to Avedon Capital, a leading mid-market private equity firm in the Benelux and DACH-region. Avedon will merge the company with Detron, an independent IT service provider. The transaction is still subject […]

Gilde Healthcare Acquires Sanquin Reagents

The specialized private equity fund invests in scaling-up production and development of new medical tests

Gilde Healthcare bolsters its Private Equity team in Frankfurt office

Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment of Martin von Berg as Investment Manager and Lara Hilgert as Investment...

Gilde Healthcare company Zetacom acquires communication specialist Ooperon

Dutch communication system integrator Zetacom B.V. announced the acquisition of communication specialist Ooperon B.V.

Gilde Healthcare invests in German precision surgical instruments contract manufacturer Chr. Diener

Leading contract manufacturer of highly complex, customer-specific, surgical instruments partners with Gilde Healthcare to further build on the company’s 122-year heritage.

Gilde Healthcare portfolio company Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions and specifically solutions for targeted radiopharmaceuticals.

Gilde Healthcare raises more than €500 million for private equity investments in European healthcare companies

Gilde Healthcare Private Equity IV raises €517 million for investments in healthcare companies in the lower mid-market in Northwest Europe Gilde Healthcare has raised €933 million ($1.0 billion) in two years for its private equity and transatlantic venture&growth funds Gilde Healthcare today announces it raised €517 million...
Loading...
These were all messages
51f739d166